Treatment of Hyperthyroidism from the Five Zang-organs

PANG Qing; NI Qing

doi:10.3969/j.issn.1673-7202.2022.13.020

Suggestions

您当前的位置：

首页 >

文章列表页 >

Treatment of Hyperthyroidism from the Five Zang-organs

Previous: Exploration of ZHANG Zhiyuan's Experience in Using Dahuang （Radix et Rhizoma Rhei） based on Dose Effect Relationship

Next: 无

Treatment of Hyperthyroidism from the Five Zang-organs
1.Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China
DOI：10.3969/j.issn.1673-7202.2022.13.020

扫描看全文

PANG Qing, NI Qing. Treatment of Hyperthyroidism from the Five Zang-organs[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1673-7202.2022.13.020
DOI：

PANG Qing, NI Qing. Treatment of Hyperthyroidism from the Five Zang-organs[DB/OL].（2023-09-15）[2023-11-05].http://cccl-tcm.cacm.org.cn/thesisDetails#10.3969/j.issn.1673-7202.2022.13.020 DOI：

摘要

甲状腺功能亢进症是一种由于多因素诱发而出现全身内外各脏腑组织器官异常的病症。其发病原因多端，临床表现多样，并常合并肝损害及白细胞减少等症。甲状腺功能亢进症的发生发展与五脏失调密切相关，肝气横逆，可上冲心肺、中犯脾胃、下耗肾阴，遍及全身各脏腑组织器官，其病机总以阴虚阳亢、五脏失调为主。因此在治疗上，应以“调理五脏，以平为期”为指导原则，根据其不同的临床表现、五脏功能失调的偏颇，在治疗上有所侧重，补其不足，损其有余，以期改善症状、改善指标、缩短疗程及防复发，提高临床疗效。

Abstract

Hyperthyroidism, caused by many factors, is characterized by the abnormality of various organs. It features diverse clinical manifestations, particularly liver damage and leukopenia. The occurrence and development of this disease is closely related to the disharmony of the five zang-organs. To be specific, the disordered qi in liver attacks the heart and lung in the upper, invades the spleen and stomach in the middle, and consumes the kidney yin, thus flowing all over the viscera, tissues and organs of the whole body. The general pathogenesis is yin deficiency and yang hyperactivity and disharmony of five zang-organs. Therefore, according to the principle of "regulating five zang-organs to achieve harmony", the treatment method is selected depending on the clinical manifestations and the dysfunction of specific organs, so as to tonify the insufficiency and damage the surplus. That is how we can alleviate the symptoms, improve indicators, shorten the course of treatment, reduce the recurrence, and improve the clinical efficacy.

关键词

甲状腺功能亢进症瘿病五脏治法

Keywords

HyperthyroidismGall diseaseFive zang-organsTherapy

references

中华医学会, 中华医学会杂志社, 中华医学会全科医学分会, 等. 甲状腺功能亢进症基层诊疗指南（2021年）[J]. 中华全科医师杂志, 2021, 20(5): 515-519.

中华医学会核医学分会. 131I治疗格雷夫斯甲亢指南（2021版）[J]. 中华核医学与分子影像杂志, 2021, 41(4): 242-253.

Ross DS, Burch HB, Cooper DS, et al. 2016 American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and Other Causes of Thyrotoxicosis[J]. Thyroid, 2016, 26(10):1343-1421.

倪青. 甲状腺功能亢进症中西医结合诊疗思路与方法[J]. 中国临床医生杂志, 2015, 43(6): 1-3,103.

Burch HB, Cooper DS. Management of Graves Disease: A Review[J]. JAMA, 2015, 314(23):2544-2554.

杨婷婷. 中西医结合治疗甲状腺功能亢进症的安全性分析——评《甲状腺疾病诊断与治疗》[J]. 中国实验方剂学杂志, 2021, 27(23): 162.

张杰, 李俊玲. 甲状腺功能亢进性心脏病的临床诊治分析[J]. 实用心脑肺血管病杂志, 2012, 20(12): 2032-2033.

王翔宇. 陈如泉从脾论治甲状腺病[J]. 湖北中医杂志, 2015, 37(6): 27.

李敏, 王旭. 浅谈从肝脾肾论治桥本甲状腺炎[J]. 四川中医, 2012, 30(1): 32-34.

全建峰, 吴承玉. 中医肾系基础证规范化研究中肾概念的探讨[J]. 辽宁中医杂志, 2010, 37(1): 48-49.

刘延青, 刘国凯, 卢云涛. 甲状腺功能亢进症从肾论治探讨[J]. 河北中医, 2019, 41(4): 620-623.

林绍基. 试论中医免疫系统──对营卫气血的再认识[J]. 天津中医, 1997(2): 82-85.

申屠埔. 初探白细胞减少与卫气关系[D]. 杭州: 浙江中医药大学, 2019.

王丽敏, 张丽艳, 谷松. 解析小柴胡汤“和法”调节自身免疫性疾病机制[J]. 中华中医药学刊, 2018, 36(1): 218-221.

Ramos-Leví AM, Marazuela M. Pathogenesis of thyroid autoimmune disease:the role of cellular mechanisms[J]. Endocrinol Nutr, 2016, 63(8):421-429.

Kristensen B. Regulatory B and T cell responses in patients with autoimmune thyroid disease and healthy controls[J]. Dan Med J, 2016, 63(2):B5177.

李翎熙, 陈迪路, 周小江. 玄参化学成分、药理活性研究进展及其质量标志物分析预测[J]. 中成药, 2020, 42(9): 2417-2426.

盖晓红, 刘素香, 任涛, 等. 黄连的化学成分及药理作用研究进展[J]. 中草药, 2018, 49(20): 4919-4927.

张露苗, 马平凡. 川芎在心血管疾病中的药理及临床应用探究[J]. 中医临床研究, 2021, 13(1): 18-20.

赵文莉, 赵晔, Yiider Tseng. 黄精药理作用研究进展[J]. 中草药, 2018, 49(18): 4439-4445.

王耀光. “肝肾同源”论初探[J]. 中医杂志, 2008, 49(1): 5-7.

李忻, 文玉敏, 严美花, 等. 浅谈肝肾同源理论的科学内涵[J]. 中华中医药杂志, 2015, 30(11): 3853-3855.

樊蔚虹, 岳广欣, 任小巧, 等. 肝肾阴虚证大鼠下丘脑-垂体-甲状腺轴的变化及中药对其调节作用[J]. 中国中医药信息杂志, 2001, 8(10): 21-23.

任伟钰, 郑宜鋆, 张月梅, 等. 当归多糖药理作用的研究进展[J]. 时珍国医国药, 2020, 31(10): 2484-2487.

温欣, 周洪雷. 鳖甲化学成分和药理药效研究进展[J]. 西北药学杂志, 2008, 23(2): 122-124.

张明发, 沈雅琴. 红景天苷及其苷元酪醇的抗炎、抗肿瘤和免疫调节作用[J]. 药物评价研究, 2013, 36(3): 228-234.

Li Y, Teng D, Ba J, et al. Efficacy and Safety of Long-Term Universal Salt Iodization on Thyroid Disorders: Epidemiological Evidence from 31 Provinces of Mainland China[J]. Thyroid, 2020, 30(4):568-579.

李兴梅, 王燕妮, 郝尧. 酸甘养阴，软坚散结方治甲亢的临床疗效及其肝保护作用观察[J]. 湖南中医药大学学报, 2017, 37(5): 540-543.

孙心怡, 缪鋆鋆, 葛静. 银甲丹治疗Graves病甲亢近期疗效及对远期复发率的影响[J]. 南京中医药大学学报, 2021, 37(3): 356-359.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Professor LI Yingcun Treating Gall Disease by Purging Liver and Regulating Qi and Blood

A case study of the treatment of a hyperthyroidism patient allergic to methimazole by Academician Tong Xiaolin

Experience Summary of LU Hao Treating Gall Disease with Haoqin Qingdan Decoction (蒿芩清胆汤) Based on "Sanjiao" Theory

Experience Summary of LU Hao Treating Gall Disease with Haoqin Qingdan Decoction(蒿芩清胆汤)Based on “Sanjiao“ Theory

Experience of Spica Prunellae, Rhizoma Dioscoreae Bulbiferae, Fructus Schisandrae Chinensis in the Treatment of Hyperthyroidism—Three Prescription by Professor TONG Xiaolin

Related Author

No data

Related Institution

School of Basic Medicine, Gansu University of Chinese Medicine

Key Laboratory of Dunhuang Medicine and Translational Science of Ministry of Education, Gansu University of Chinese Medicine

Guang’anmen Hospital of China Academy of Chinese Medical Sciences

Beijing University of Chinese Medicine

Gansu University of Chinese Medicine

⁰